Spanish Red Biotech Pipeline

Gilead Sciences

Magrolimab + chemotherapy

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Solid tumors
Phase: 2Phase II in Spain, 1Phase I in Spain